NCT00036439View on ClinicalTrials.gov

A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis

PHASE3CompletedINTERVENTIONAL
Enrollment

364

Participants

Timeline

Start Date

February 28, 2002

Study Completion Date

January 31, 2007

Conditions
Ulcerative Colitis
Interventions
DRUG

Infliximab

Sponsors

Lead Sponsor

Centocor, Inc.
All Listed Sponsors
lead

Centocor, Inc.

INDUSTRY

NCT00036439 - A Safety and Efficacy Study for Infliximab (Remicade) in Patients With Active Ulcerative Colitis | Biotech Hunter | Biotech Hunter